Efficacy and Safety of Covid-19 Vaccine in Cardiac Patients

Mina sobhi said fam

Status: Unknown

Conditions: COVID-19 Vaccine

Study type: Observational

Funder types: Other

Identifiers

NCT05348629

covid-19 vaccine

Details and patient eligibility

About

Efficacy and safety of covid-19 vaccine in Cardiac patients

Full description

investigate the efficacy and safety of covid-19 vaccine in cardiac patients and its possible assocciated morbidity

Enrollment: 50 estimated patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subjects diagnosed as STEMI undergo PPCI as (Fourth universal definition of myocardial infarction (2018) Kristian Thygesen) 10
• with age range from 18 to 80 years after 1 month of STEMI .

Exclusion criteria

• Patients with previous covid infection confirmed by swap or CT chest or ICU addmision.
• Patients with previous covid infection confirmed by qualitative antibdy test .
• Patients with history of anaphylaxis to any component of the vaccine should not take it .
• patients with febrile illness or acute , ongoing infection .
• immunosuppressive diseases .